[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100513204":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":22,"centralContacts":26,"locations":33,"responsibleParty":50,"collaborators":31,"id":53,"slug":54,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":57,"acronym":31,"eligibilityCriteria":58,"healthyVolunteers":55,"sex":59,"minAge":60,"maxAge":31,"enrollmentInfo":61,"targetDuration":31,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":31,"overallStatus":35,"whyStopped":31,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"Stanford University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Ketamine","EXPERIMENTAL","Study participants will receive 0.5mg\u002Fkg of ketamine - one single infusion",[13],"Drug: Ketamine Hydrochloride",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DRUG","Ketamine Hydrochloride","Ketamine is an FDA-approved dissociative anesthetic.",[9],[21],"Ketalar",[23],{"name":24,"affiliation":5,"role":25},"Karl Deisseroth, MD, PhD","PRINCIPAL_INVESTIGATOR",[27],{"name":28,"role":29,"phone":30,"phoneExt":31,"email":32},"Arjay Cordero","CONTACT","650-580-9000",null,"arjayc@stanford.edu",[34],{"facility":5,"status":35,"city":36,"state":37,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"RECRUITING","Palo Alto","California","94306","United States","US",{"type":42,"coordinates":43},"Point",[44,45],-122.14302,37.44188,{"lat":45,"lon":44},[48],{"name":49,"role":29,"phone":31,"phoneExt":31,"email":31},"Kishandra Patron, BS",{"type":25,"investigatorFullName":51,"investigatorTitle":52,"investigatorAffiliation":5,"oldNameTitle":31,"oldOrganization":31},"Karl Deisseroth","Professor","100513204","phase-1-hnc-human-neural-circuits-electrophysiology-during-cognition-100513204",false,"NCT05962424","HNC: Human Neural Circuits Electrophysiology During Cognition","Inclusion Criteria:\n\n* Patient in clinical neuro inpatient units at Stanford Medical Center\n* Age \\>18 years old\n* Female participants are expected to use an effective method of birth control throughout the study which includes: hormonal methods (birth control pills, patches, injections, vaginal ring or implants), barrier methods (condom or diaphragm) used with spermicide, intrauterine device (IUD), or abstinence (no sex)\n\nExclusion Criteria:\n\n* Lifetime psychotic disorder\n* Pregnant or nursing females\n* Prior adverse ketamine response\n* Use of ketamine in past 7 days","ALL","18 Years",{"count":62,"type":63},120,"ESTIMATED","INTERVENTIONAL",[66],"PHASE1","The purpose of this study is to understand how ketamine brings about dissociative symptoms.",[69],"Psychiatric Disorder","2026-04-21",{"date":72,"type":73},"2026-04-22","ACTUAL",{"date":75,"type":73},"2023-10-05",{"date":77,"type":63},"2030-09-01",{"name":5,"class":6},1]